Special Seminar: Prof Adrian Krainer, USA

From Base Pairs to Bedside: Antisense Therapeutics for Splicing Modulation

14 May 2019, 12:00 
Tel Aviv University 
 
You are invited to attend the Department of Human Molecular Genetics & Biochemistry special seminar, "From Base Pairs to Bedside: Antisense Therapuetics for Splicing Modulation"  with Prof. Adrian Krainer, Cold Spring Harbor Laboratories, USA
 
Prof. Krainer is a recipient of an honorary award from Tel Aviv University for the invention of the first RNA-targeted antisense therapeutic Spinraza. This is the first drug approved to treat the neurodegenerative disease spinal muscular atrophy 
 
Date: 14/5/19
 
Time: 12:00
 
Location: Lola Hall, Sackler School of Medicine
 
Host: Gil Ast
 
 
 
 

 

 

 

Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
UI/UX Basch_Interactive